US Patent 11248045 Anti-human transferrin receptor antibody permeating blood-brain barrier
Patent 11248045 was granted and assigned to JCR Pharmaceuticals on February, 2022 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11248045 Anti-human transferrin receptor antibody permeating blood-brain barrier
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
